Meiling Hu
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA modifications and cancer 3
-
- Plant nutrient uptake and metabolism 2
- Co-authors
- Hongli Du (11 shared papers)Jinfen Wei (9 shared papers)Shudai Lin (5 shared papers)Zixi Chen (7 shared papers)Yunmeng Bai (4 shared papers)Xiangliang Yang (1 shared paper)Huibi Xu (1 shared paper)Chengbin Xue (1 shared paper)
- Journals
- International Journal of Molecular Sciences (3 papers)Frontiers in Immunology (2 papers)Bioinformatics (1 paper)BMC Plant Biology (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Meiling Hu
52 papers receiving 964 citations
Peers
Comparison fields: 5 of 113
- Pharmaceutical Science 109
- Cancer Research 122
- Immunology 117
- Health Informatics 8
- Molecular Biology 377
Countries citing papers authored by Meiling Hu
This map shows the geographic impact of Meiling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Hu more than expected).
Fields of papers citing papers by Meiling Hu
This network shows the impact of papers produced by Meiling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Hu. The network helps show where Meiling Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 132 | |
| 2 | 2020 | 119 | |
| 3 | 2020 | 87 | |
| 4 | 2018 | 77 | |
| 5 | 2017 | 64 | |
| 6 | 2021 | 59 | |
| 7 | 2021 | 45 | |
| 8 | 2018 | 36 | |
| 9 | 2020 | 27 | |
| 10 | 2014 | 25 | |
| 11 | 2022 | 23 | |
| 12 | 2024 | 21 | |
| 13 | 2020 | 19 | |
| 14 | 2023 | 18 | |
| 15 | 2012 | 17 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2025 | 12 | |
| 20 | 2023 | 11 |
About Meiling Hu
Meiling Hu is a scholar working on Molecular Biology, Plant Science, Cancer Research, Oncology and Immunology, having authored 56 papers that have together received 977 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Brain Metastases and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Plant nutrient uptake and metabolism (2 papers). The work is most often cited by research in Pharmaceutical Science (109 citations), Cancer Research (122 citations), Immunology (117 citations), Health Informatics (8 citations) and Molecular Biology (377 citations). Meiling Hu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Hongli Du, Jinfen Wei, Shudai Lin, Zixi Chen, Yunmeng Bai, Xiangliang Yang, Huibi Xu, Chengbin Xue, Wei Liu and Heng Sun. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Immunology, Bioinformatics, BMC Plant Biology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.